Cas
- 17631-67-3
- GADOLINIUM 6,6,7,7,8,8,8-HEPTAFLUORO-2,2-DIMETHYL-3,5-OCTANEDIONATE
- GADOLINIUM 6,6,7,7,8,8,8-HEPTAFLUORO-2,2-DIMETHYL-3,5-OCTANEDIONATE
- GADOTERIDOL RELATED COMPOUND A 10-(2-HYDROXYPROPYL)-1,4,7,10-TETRAAZACYCLODEDODECANE-1,4,7-TRIAACETIC ACID USP(CRM STANDARD)
- GADOTERIDOL RELATED COMPOUND A 10-(2-HYDROXYPROPYL)-1,4,7,10-TETRAAZACYCLODEDODECANE-1,4,7-TRIAACETIC ACID USP(CRM STANDARD)
- GADOTERIDOL RELATED COMPOUND B1,4,7,10-TETRAAZACYCLODODECANE-1,4,7-TRIACETIC ACID, MONOGADOLINIUM SALT USP(CRM STANDARD)
- GADOTERIDOL RELATED COMPOUND B1,4,7,10-TETRAAZACYCLODODECANE-1,4,7-TRIACETIC ACID, MONOGADOLINIUM SALT USP(CRM STANDARD)
- 112188-16-6
- ガドテリドール RELATED COMPOUND B (1,4,7,10-テトラアザシクロドデカン-1,4,7-三酢酸, 一ガドリニウム塩)
- GADOTERIDOL RELATED COMPOUND B (50 MG) (1,4,7,10-TETRAAZACYCLODODECANE-1,4,7-TRIACETIC ACID, MONOGADOLINIUM SALT)
- Gadoversetamide Related Compound A (200 mg) (Hydrogen[8,11,14-tris(carboxymethyl)-6-oxo-2-oxa-5,8,11,14-tetraazahexadecan-16-oato(4-)]gadolinium)
- Gadoversetamide Related Compound A (200 mg) (Hydrogen[8,11,14-tris(carboxymethyl)-6-oxo-2-oxa-5,8,11,14-tetraazahexadecan-16-oato(4-)]gadolinium)
- GADOVERSETAMIDE RELATED COMPOUND AHYDROGEN[8,11,14-TRIS(CARBOXYMETHYL)-6-OXO-2-OXA-5,8,11,14-TETRAAZAHEXADECAN-16-OATO(4-)]GADOLINIUM USP(CRM STANDARD)
- GADOVERSETAMIDE RELATED COMPOUND AHYDROGEN[8,11,14-TRIS(CARBOXYMETHYL)-6-OXO-2-OXA-5,8,11,14-TETRAAZAHEXADECAN-16-OATO(4-)]GADOLINIUM USP(CRM STANDARD)